Parojinog, Jovil A.

HRN: 21-93-16  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/21/2022
CEFUROXIME 750MG (VIAL)
09/21/2022
09/27/2022
IV
750mg
Q8
T/C UTI
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: No  Wrong Dose  Optimize Dose

Overall appropriateness: No  Optimize Dose

Intervention



Type of Intervention done:

                    

           


Acceptance: